Henry is a Vice President of Data Sciences at Medidata. His team’s mission is to build scalable data science and engineering software services that are integrated into Medidata platform to accelerate the generation of actionable insights across the clinical development lifecycle. Previously, he has led and worked on data science teams across different functions at Janssen Pharmaceuticals, Johnson & Johnson Medical Device Companies and Roche Pharmaceuticals. Henry earned his B.S. in Electrical Engineering & Computer Science from UC Berkeley and Ph.D. in Biological & Medical Informatics from UCSF.
Archives: Speakers
Meghan Harrington
Meghan serves as the VP, Clinical Trial Financial Management at Medidata driving roadmap and strategy across our Grants Manager and Site Payments products. Meghan started her career as a Masters level psychologist working within a medical care team treating patients with ALS and traumatic brain injury. It was through this privileged relationship with patients facing devastating diagnoses that Meghan witnessed first hand the life-saving and life-enhancing effects of medical and therapeutic intervention thus piquing her interest in the drug development process. Meghan joined a CNS-focused start up in RTP and has spent the last 15+ years working in the life science technology industry. The last decade of this time has been solely focused on the investigator grant administration domain driving strategy and leading teams implementing payment technology in both BPO and enablement models.
Benjamin Labrousse
Christopher Baxter
James Bernstein
Brendan Krause
Brendan has over 20 years of policy, strategy and business development experience in health
care. He began his career at the National Governors Association in Washington, DC, working
on health reform between the US Federal Government and states. Following NGA, Brendan
attended the London School of Economics as a Fulbright Scholar, where he studied the impact
of the Blair Government’s choice and competition reforms in the NHS and earned an MSc in
International Health Policy and Economics. He then spent 12 years working for Optum in the
UK in a number of UK and global strategy roles, with a focus on use of data to improve
population health. Recently, Brendan joined Uber as Head of International for Health, where he
is building a global strategy to remove transportation and logistics as a barrier to care.
Paul Finney
Paul has 28 years’ experience working in Life Sciences; 7 researching Respiratory indications (asthma, COPD, PPH) and 9 years in Clinical Research for emerging Biotechs managing programs in across Respiratory, Oncology, Gastro-Enterology, Endocrinology therapeutic areas. Over the last 12 years Paul has specialised in eClinical, working for CROs and technology providers with a focus on clinical trial processes, ICH GCP, the use of technology to solve industry problems, and is also an SME in RBQM.
Ursina Lüthi
Ursina Lüthi has been Chief Product Officer at ECOFIN Software and Technology AG – the Finfox company – since 2020. She joined ECOFIN in 1995, held various leading positions within the firm and has been a member of the Executive Board since 2002. Ursina is the mastermind of Finfox, having been in charge of the solution and its continuous development since the very beginning in 2007. Over the last 25 years she has gained deep expertise in product development, product strategy and consulting in the area of wealth advisory services. Ursina graduated in Business and Economics from the University of Zurich. She is fluent in five languages including her mother tongue Rhaeto-Romanic.
Matt Arnull
Matt is head of architecture and strategy, developing the future Technology strategy for Whitbread, covering a major period of investment in our core technology to help prepare the business for the accelerating demand for digital services and further growth, both in the UK and beyond.